EA200802136A1 - Лечение меланомы - Google Patents

Лечение меланомы

Info

Publication number
EA200802136A1
EA200802136A1 EA200802136A EA200802136A EA200802136A1 EA 200802136 A1 EA200802136 A1 EA 200802136A1 EA 200802136 A EA200802136 A EA 200802136A EA 200802136 A EA200802136 A EA 200802136A EA 200802136 A1 EA200802136 A1 EA 200802136A1
Authority
EA
Eurasian Patent Office
Prior art keywords
melanoma
treatment
administered
inhibit
treat
Prior art date
Application number
EA200802136A
Other languages
English (en)
Other versions
EA016660B1 (ru
Inventor
Синтия У. Татхилл
Алфред Р. Рудолф
Original Assignee
Сциклон Фармасьютиклз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38625521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200802136(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Сциклон Фармасьютиклз, Инк. filed Critical Сциклон Фармасьютиклз, Инк.
Publication of EA200802136A1 publication Critical patent/EA200802136A1/ru
Publication of EA016660B1 publication Critical patent/EA016660B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В заявке описано иммуномодуляторное соединение, которое вводят для лечения, предупреждения, ингибирования или уменьшения меланомы у индивидуума.
EA200802136A 2006-04-20 2007-04-13 Способ лечения меланомы EA016660B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79324306P 2006-04-20 2006-04-20
PCT/US2007/009049 WO2007123847A2 (en) 2006-04-20 2007-04-13 Treatment of melanoma

Publications (2)

Publication Number Publication Date
EA200802136A1 true EA200802136A1 (ru) 2009-04-28
EA016660B1 EA016660B1 (ru) 2012-06-29

Family

ID=38625521

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200802136A EA016660B1 (ru) 2006-04-20 2007-04-13 Способ лечения меланомы

Country Status (13)

Country Link
US (1) US8163702B2 (ru)
EP (1) EP2029154A4 (ru)
JP (1) JP2009534383A (ru)
CN (1) CN101448514A (ru)
AR (1) AR060566A1 (ru)
AU (1) AU2007240946A1 (ru)
BR (1) BRPI0711567A2 (ru)
CA (1) CA2649575A1 (ru)
EA (1) EA016660B1 (ru)
IL (1) IL194798A0 (ru)
MX (1) MX2008013329A (ru)
TW (1) TW200808337A (ru)
WO (1) WO2007123847A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090074815A1 (en) * 2005-04-22 2009-03-19 Sciclone Pharmaceuticals, Inc. Immunomodulator Compounds as Vaccine Enhancers
EP2120986A4 (en) * 2007-02-13 2010-04-07 Sciclone Pharmaceuticals Inc METHOD FOR THE TREATMENT OR PREVENTION OF TISSUE WEAR, INJURY OR DAMAGE CAUSED BY SLEWER DISEASES
RU2615908C1 (ru) * 2016-05-16 2017-04-11 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ моделирования лимфогенного и гематогенного метастазирования мышиной меланомы В16 у белых нелинейных крыс

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758551A (en) * 1986-07-08 1988-07-19 Cornell Research Foundation, Inc. Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
WO1997019691A1 (en) 1995-11-28 1997-06-05 Wei, Edward, T. Gamma-l-glutamyl containing immunomodulator compounds and methods therewith
RU2091389C1 (ru) 1995-11-28 1997-09-27 Товарищество с ограниченной ответственностью "Верта" Пептид, обладающий иммуномодулирующей активностью

Also Published As

Publication number Publication date
BRPI0711567A2 (pt) 2011-11-08
US8163702B2 (en) 2012-04-24
MX2008013329A (es) 2008-11-18
US20090088392A1 (en) 2009-04-02
TW200808337A (en) 2008-02-16
IL194798A0 (en) 2011-08-01
CA2649575A1 (en) 2007-11-01
WO2007123847A2 (en) 2007-11-01
AR060566A1 (es) 2008-06-25
CN101448514A (zh) 2009-06-03
AU2007240946A1 (en) 2007-11-01
EP2029154A2 (en) 2009-03-04
EA016660B1 (ru) 2012-06-29
WO2007123847A3 (en) 2008-06-26
JP2009534383A (ja) 2009-09-24
EP2029154A4 (en) 2012-04-04

Similar Documents

Publication Publication Date Title
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
EA201170832A1 (ru) Пуриновые соединения
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA200801897A1 (ru) Ингибиторы mnk2 на основе 8-гетероарилпурина для лечения метаболических нарушений
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
MX2009011002A (es) Composiciones de proteccion de isquemia/reperfusion y metodos de uso.
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
EA201170521A1 (ru) Новые соединения
EA200970542A1 (ru) ИНГИБИТОРЫ ДЕЙСТВИЯ Akt
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201170349A1 (ru) Модуляторы mif
TNSN08400A1 (en) Organic compounds and their uses
EA201101117A1 (ru) Ингибиторы дпп-4 для лечения диабета у детей
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
TN2011000482A1 (en) Organic compounds and their uses
GEP20166443B (en) Heterocyclic compound and use thereof
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
BRPI0908635A8 (pt) composto, composição farmacêutica e método de tratamento de câncer
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
UA114417C2 (uk) Інгібітори iap
EA200702510A1 (ru) Способы защиты от апоптоза с применением липопептидов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU